IL17A and colitis: In summary, our findings show that M2b macrophage exosomes attenuate disease activity, up-regulate Treg cells and IL-4, and reduce pro-inflammatory cytokine (IL-1β, IL-6, and IL-17A) production in mice with DSS-induced colitis.